|
Name: Brivaracetam
Type: Anticonvulsant
AKA: ['BRV', 'UCB-34714', 'Briviact', '((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide)']
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Brivaracetam, an antiepileptic drug, was developed in the 2010s. It is used to treat epilepsy and seizures, providing a new option for managing epilepsy in patients who do not respond well to other treatments.
|
|
V. Legal Information
Brivaracetam, an anticonvulsant, is classified as a Schedule V controlled substance in the US, reflecting a lower potential for abuse. It is approved for medical use in many countries for treating epilepsy. Regulatory bodies like the FDA ensure its safe prescription. The UNODC does not classify it as a major concern. Trends show a steady acceptance for its therapeutic use.
US Federal Schedule - V
Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are: cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Brivaracetam is an antiepileptic drug used to treat seizures. It can cause dizziness, drowsiness, and reduced heart rate. Short-term use is effective in seizure management, while long-term use is generally safe with minimal risk of dependence. Overdose risks include severe sedation and potential cardiovascular effects. Safe use involves following prescribed dosages. Recent research supports its efficacy in managing seizures and highlights its safety profile.  |
|
VII. Psychological Effects
Brivaracetam, an antiepileptic, affects synaptic vesicle protein 2A (SV2A), stabilizing mood and reducing seizures. Immediate effects include mood enhancement and cognitive stabilization, while long-term use supports overall mental well-being. Research indicates benefits for seizure control and mood stabilization, with minimal risks of mental health issues.
 |
|
VIII. Culture
Brivaracetam is an anticonvulsant used to manage epilepsy. Its cultural significance lies in its role in treating seizures and its impact on epilepsy management. Media coverage often discusses its efficacy, safety profile, and its place among other antiepileptic drugs. Brivaracetam is used medicinally and is part of broader discussions about epilepsy treatment and drug development.
 |